Noninfectious Uveitis Affecting the Posterior Segment

• FDA approval · 2022-12-19
  FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)

  The FDA approved a supplemental application for OZURDEX (dexamethasone intravitreal implant) from Allergan, Inc., resulting in labeling chan…

• FDA approval · 2011-06-02
  FDA Approved: RETISERT — Supplemental Application (Bausch & Lomb Incorporated)

  FDA approved a supplemental application for RETISERT (fluocinolone acetonide) by Bausch & Lomb Incorporated.